Cardinal Health Inc. (CAH) Financial Statements (2025 and earlier)

Company Profile

Business Address 7000 CARDINAL PLACE
DUBLIN, OH 43017
State of Incorp. OH
Fiscal Year End June 30
Industry (SIC) 5122 - Drugs, Drug Proprietaries, and Druggists' Sundries (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in millions)

6/30/2025
12/31/2024
MRQ
6/30/2024
6/30/2023
6/30/2022
6/30/2021
6/30/2020
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments3,8105,1334,0434,7173,4072,771
Cash and cash equivalent3,8105,1334,0434,7173,4072,771
Receivables12,36912,08411,34410,5619,1038,264
Inventory, net of allowances, customer advances and progress billings16,90414,95715,94015,63614,59413,198
Inventory16,90414,95715,94015,63614,59413,198
Other current assets2,6232,6632,3622,0212,8431,707
Other undisclosed current assets5047144 1,101 
Total current assets:35,75634,88433,83332,93531,04825,940
Noncurrent Assets
Property, plant and equipment2,5582,5292,4622,3612,3602,366
Intangible assets, net (including goodwill)7,4366,4506,0817,62910,09411,275
Goodwill5,4884,7254,6095,8557,9898,357
Intangible assets, net (excluding goodwill)1,9481,7251,4721,7742,1052,918
Other noncurrent assets1,2521,2581,0419539511,185
Total noncurrent assets:11,24610,2379,58410,94313,40514,826
TOTAL ASSETS:47,00245,12143,41743,87844,45340,766
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities34,67935,20632,87229,97026,65723,605
Accounts payable31,29831,75929,81327,12823,70021,374
Accrued liabilities3,3813,4473,0592,8422,9572,231
Debt54443479258087110
Other undisclosed current liabilities   42 96 
Total current liabilities:35,22335,64033,70630,55027,62423,615
Noncurrent Liabilities
Long-term debt and lease obligation, including:7,0624,6583,9094,7355,3656,765
Finance lease, liability 7559494525
Other undisclosed long-term debt and lease obligation7,0624,5833,8504,2985,3206,399
Liabilities, other than long-term debt 400375   
Operating lease, liability 400375388 341
Other undisclosed noncurrent liabilities7,6387,6358,2788,9119,6708,253
Total noncurrent liabilities:14,70012,69312,56214,03415,03515,359
Total liabilities:49,92348,33346,26844,58442,65938,974
Equity
Equity, attributable to parent(2,991)(3,213)(2,852)(709)1,7911,789
Common stock2,9322,9172,7472,8132,8062,789
Treasury stock, value(6,026)(5,677)(4,914)(3,128)(2,186)(2,066)
Accumulated other comprehensive loss(180)(167)(151)(114)(34)(104)
Retained earnings (accumulated deficit)283(286)(534)(280)1,2051,170
Equity, attributable to noncontrolling interest7011333
Total equity:(2,921)(3,212)(2,851)(706)1,7941,792
TOTAL LIABILITIES AND EQUITY:47,00245,12143,41743,87844,45340,766

Income Statement (P&L) ($ in millions)

6/30/2025
12/31/2024
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
6/30/2020
Revenues222,160226,827205,012181,364162,467152,922
Cost of revenue
(Cost of Product and Service Sold)
(214,517)(219,413)(198,123)(174,819)(155,689)(146,054)
Gross profit:7,6437,4146,8896,5456,7786,868
Operating expenses(5,317)(5,253)(4,627)(4,767)(5,776)(10,435)
Other undisclosed operating loss(434)(918)(1,535)(2,374)(530)(531)
Operating income (loss):1,8921,243727(596)472(4,098)
Nonoperating income (expense)
(Other Nonoperating Income (Expense))
(7)94(16)471
Interest and debt expense  (51)(93)(159)(194)(254)
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes     (2)579
Income (loss) from continuing operations before equity method investments, income taxes:1,8851,201638(771)323(3,772)
Income from equity method investments      2
Other undisclosed income (loss) from continuing operations before income taxes(96)  2  
Income (loss) from continuing operations before income taxes:1,7891,201638(769)323(3,770)
Income tax expense (benefit)(478)(348)(376)(163)28979
Income (loss) from continuing operations:1,311853262(932)612(3,691)
Income (loss) before gain (loss) on sale of properties:(932)612(3,691)
Other undisclosed net loss      (2)
Net income (loss):1,311853262(932)612(3,693)
Net loss attributable to noncontrolling interest(1)(1)(1)(1)(1)(3)
Net income (loss) available to common stockholders, diluted:1,310852261(933)611(3,696)

Comprehensive Income ($ in millions)

6/30/2025
12/31/2024
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
6/30/2020
Net income (loss):1,311853262(932)612(3,693)
Other comprehensive income (loss)(25)(16)(37)(80)70(25)
Comprehensive income (loss):1,286837225(1,012)682(3,718)
Comprehensive loss, net of tax, attributable to noncontrolling interest(1)(1)(1)(1)(1)(3)
Comprehensive income (loss), net of tax, attributable to parent:1,285836224(1,013)681(3,721)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: